Sort
261,768 grants matching “gene therapy”
Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery
$1,545,877Martin R. Pollak · Beth Israel Deaconess Medical Center · RC2 · FY2020 · DK
Gene and Pharmacological Therapies for Cystic Fibrosis
$1,545,724William B. Guggino · Johns Hopkins University · P01 · FY2006 · HL
IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine
$1,545,717Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA
Molecular Genetics Of Heritable Human Disorders
$1,545,705Janice Chou · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD
Protective Genetic Variants for Alzheimer Disease in the Amish - RENEWAL
$1,545,583Jonathan L. Haines · Case Western Reserve University · R01 · FY2025 · AG
Developmental Mechanisms of Human Idiopathic Scoliosis
$1,545,569Carol A Wise · Ut Southwestern Medical Center · P01 · FY2016 · HD
Improved Dosing and Refinement of a Cardiac Targeted Gene Therapy in a Swine Infarct Model
$1,545,537Sam Teichman · Beat Biotherapeutics Corporation · R44 · FY2016 · HL
Initiation of DNA Replication in Mammalian Cells
$1,545,289Mirit Aladjem · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
University of Washington Interdisciplinary Center for Exposures, Diseases, Genomics & Environment
$1,545,000Terrance J Kavanagh · University Of Washington · P30 · FY2016 · ES
Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy
$1,545,000Ohannes Kevork Melemedjian · University Of Maryland Baltimore · R01 · FY2020 · CA
Validating ASCT2 for the Treatment of Chronic Postsurgical Pain
$1,545,000Ohannes Kevork Melemedjian · University Of Maryland Baltimore · R01 · FY2020 · NS
University of Washington Interdisciplinary Center for Exposures, Diseases, Genomics & Environment
$1,544,846Terrance J Kavanagh · University Of Washington · P30 · FY2017 · ES
5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
$1,544,813Matthew Wayne Johnson · Johns Hopkins University · U01 · FY2022 · DA
Metabolic Networks and Pathways in Alzheimer's Disease
$1,544,530Rima F Kaddurah-Daouk · Duke University · R01 · FY2016 · AG
HOPE in Action: A clinical trial of HIV-to-HIV deceased donor kidney transplantation
$1,544,393Christine Marie Durand · Johns Hopkins University · U01 · FY2019 · AI
Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy
$1,544,379Yaron Rotman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
MITOCHONDRIAL ENCEPHALOMYOPATHIES: APPROACHES TO TREATMENT
$1,544,137Salvatore Dimauro · Columbia University Health Sciences · P01 · FY2016 · HD
Disruption of Transcription Networks in Esophageal Adenocarcinoma Tumorigenesis
$1,544,026Wael El-Rifai · University Of Miami School Of Medicine · P01 · FY2025 · CA
Natural History of HPV Infection to Neoplasia
$1,543,996Anna-Barbara None Moscicki · University Of California, San Francisco · R37 · FY2007 · CA
Optimization of gene transfer and gene editing safety and efficacy focusing on the NHP model
$1,543,957Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Clonal analysis of in vivo hematopoiesis
$1,543,957Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Combinations of Synergistic Bispecific Human Antibodies: A Novel Strategy for the Treatment of Neuroblastoma
$1,543,917James M Olson · Fred Hutchinson Cancer Research Center · U01 · FY2018 · CA
Mouse Mutant Resource
$1,543,801Leah Rae B Donahue · Jackson Laboratory · P40 · FY2009 · RR
A Phase 1b Multiple Ascending Dose Study of the Safety and Tolerability of BMS-984923 in Alzheimer's Disease
$1,543,652Adam Peter Mecca · Yale University · R01 · FY2022 · AG
Primary Immune Deficiency Treatment Consortium
$1,543,499Morton Cowan · University Of California, San Francisco · U54 · FY2015 · AI